Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2012 |  NVAX Novavax, Inc. - Common Stock | 11.01 USD | -1.87% | +2.32% | +14.21% | +27.87% | 1.82 B USD | ||
| 2019 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 36.98 USD | -9.14% | -9.65% | -15.61% | +94.63% | 1.81 B USD | ||
| 2022 |  BHVN Biohaven Ltd. Common Shares | 11.94 USD | +0.34% | -10.70% | -17.66% | -29.52% | 1.80 B USD | ||
| 2027 |  ZYME Zymeworks Inc. - Common Stock | 25.26 USD | -4.79% | -2.77% | -9.17% | +42.39% | 1.79 B USD | ||
| 2031 |  MESO Mesoblast Limited - American Depositary Shares | 13.75 USD | -1.36% | -4.11% | -12.97% | -27.97% | 1.78 B USD | ||
| 2039 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.60 USD | +7.60% | +1.45% | +0.80% | -8.16% | 1.77 B USD | ||
| 2046 |  NUVB Nuvation Bio Inc. Class A Common Stock | 4.98 USD | +2.26% | -12.01% | -22.07% | +31.40% | 1.75 B USD | ||
| 2053 |  SEPN Septerna, Inc. - Common Stock | 36.90 USD | +2.50% | -4.99% | -0.67% | +67.65% | 1.72 B USD | ||
| 2060 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 26.24 USD | -6.88% | -7.83% | -20.53% | -0.83% | 1.71 B USD | ||
| 2087 |  OCUL Ocular Therapeutix, Inc. - Common Stock | 7.51 USD | +3.87% | +1.21% | -33.19% | -34.70% | 1.65 B USD | ||
| 2121 |  QURE uniQure N.V. - Ordinary Shares | 22.54 USD | -2.59% | -4.97% | -50.66% | -64.64% | 1.56 B USD | ||
| 2126 |  STOK Stoke Therapeutics, Inc. - Common Stock | 23.95 USD | -1.40% | -9.04% | -19.14% | -22.62% | 1.55 B USD | ||
| 2130 |  ABSI Absci Corporation - Common Stock | 8.94 USD | -3.04% | -19.75% | +6.81% | +122.39% | 1.53 B USD | ||
| 2143 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 16.90 USD | -0.76% | -8.45% | -14.08% | +3.81% | 1.51 B USD | ||
| 2144 |  INVA Innoviva, Inc. - Common Stock | 20.87 USD | -0.90% | +1.31% | -1.37% | +17.12% | 1.51 B USD | ||
| 2145 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.29 USD | +2.69% | +2.62% | +7.60% | -51.93% | 1.51 B USD | ||
| 2152 |  IMCR Immunocore Holdings plc - American Depositary Shares | 29.09 USD | -1.09% | -5.49% | -17.26% | -13.11% | 1.50 B USD | ||
| 2165 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 4.43 USD | 0.00% | -7.71% | -15.46% | -12.97% | 1.44 B USD | ||
| 2192 |  NKTR Nektar Therapeutics - Common Stock | 40.80 USD | +1.34% | -11.78% | -45.67% | -44.32% | 1.39 B USD | ||
| 2198 |  OMER Omeros Corporation - Common Stock | 19.12 USD | +1.97% | +2.80% | 0.00% | +316.56% | 1.38 B USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |